Unknown NA INTERVENTIONAL 2-arm NCT04425772

A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）

A Randomized,Double Blinded, Double Dummy, Parallel Controlled Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）

Sponsor: Henan Genuine Biotech Co., Ltd.

Conditions COVID-19

Interventions FNC dummy tablet+Standard of Care FNC+Standard of Care

Updated 6 times since 2020 Last updated: Jun 8, 2020 Started: Jun 12, 2020 Primary completion: Aug 12, 2020 Completion: Aug 12, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on COVID-19, this trial is ongoing. The trial is conducted by Henan Genuine Biotech Co., Ltd. and has accumulated 6 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Jun 2025 — Present [monthly]

Unknown NA
Sep 2024 — Jun 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jul 2022 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jul 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Henan Genuine Biotech Co., Ltd.

Data source: Henan Genuine Biotech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.